Detalles de la búsqueda
1.
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.
Rheumatology (Oxford)
; 62(10): 3382-3390, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36810788
2.
18F-sodium fluoride PET-CT visualizes both axial and peripheral new bone formation in psoriatic arthritis patients.
Eur J Nucl Med Mol Imaging
; 50(3): 756-764, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370181
3.
Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate.
Ann Rheum Dis
; 78(5): 610-616, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808625
4.
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.
Ann Rheum Dis
; 77(2): 251-257, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080861
5.
Residual disease activity in psoriatic arthritis: discordance between the rheumatologist's opinion and minimal disease activity measurement.
Rheumatology (Oxford)
; 57(2): 283-290, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28541484
6.
Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al.
Ann Rheum Dis
; 79(11): e143, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31331923
7.
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al.
Ann Rheum Dis
; 78(7): e62, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29776975
8.
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up.
Ann Rheum Dis
; 73(12): 2178-82, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115447
9.
Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
Joint Bone Spine
; 91(3): 105683, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38161051
10.
Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.
Rheumatol Ther
; 11(3): 795-815, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38662145
11.
Brief report: a phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis.
Arthritis Rheum
; 64(6): 1750-5, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22170479
12.
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated.
RMD Open
; 9(4)2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38053460
13.
Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
J Rheumatol
; 50(2): 265-278, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319013
14.
A prospective, randomized, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on lesional and nonlesional skin.
Dermatology
; 225(4): 298-303, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23257348
15.
Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.
Curr Rheumatol Rep
; 13(4): 353-9, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21503693
16.
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.
Ann Rheum Dis
; 69(11): 2013-6, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20693270
17.
Response to comments on "Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women" by Koet.
Semin Arthritis Rheum
; 65: 152394, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368731
18.
Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial.
Arthritis Res Ther
; 21(1): 208, 2019 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31521192
19.
Brief Report: Interleukin-17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses.
Arthritis Rheumatol
; 70(12): 1994-2002, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29869838
20.
Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.
J Rheumatol
; 45(9): 1256-1262, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29907666